Cargando…

A lurking threat: transfer of peanut allergy through peripheral blood stem cell transplantation

BACKGROUND: There exist several reports of atopy and allergen-specific IgE-mediated hypersensitivity transferred by bone marrow transplantation, and it has been concluded that the transfer of allergic reactivity results from adoptive transfer of IgE-producing donor-derived B- and/or plasma cells. To...

Descripción completa

Detalles Bibliográficos
Autores principales: Brauns, Birka, Schön, Michael P., Wulf, Gerald, Mempel, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745161/
https://www.ncbi.nlm.nih.gov/pubmed/26904156
http://dx.doi.org/10.1186/s40413-016-0093-4
_version_ 1782414589612261376
author Brauns, Birka
Schön, Michael P.
Wulf, Gerald
Mempel, Martin
author_facet Brauns, Birka
Schön, Michael P.
Wulf, Gerald
Mempel, Martin
author_sort Brauns, Birka
collection PubMed
description BACKGROUND: There exist several reports of atopy and allergen-specific IgE-mediated hypersensitivity transferred by bone marrow transplantation, and it has been concluded that the transfer of allergic reactivity results from adoptive transfer of IgE-producing donor-derived B- and/or plasma cells. To the best of our knowledge we report the first case of peanut allergy after PBSCT. CASE PRESENTATION: A 55-year-old anciently non allergic man with secondary acute myeloid leukemia (AML) received an allogeneic peripheral blood stem cell transplantation from a matched unrelated donor following reduced-intensity conditioning. On day 32 after PBSCT, while still on prophylactic systemic immunosuppression, the patient noticed a first episode of angioedema with swelling of the nasal and oral mucosa 30 min after consuming peanut puffs. In a second episode, eight months after PBSCT, he again developed angioedema, generalized pruritus and nausea within minutes after eating biscuits containing hazelnut and peanut. Moreover, after topical application of a peanut oil-containing ointment, the patient experienced facial erythema and angioedema. Nine months after PBSCT an evaluation for peanut allergy revealed a highly increased specific IgE to peanut of 75.9 kU/l. Accordingly, skin prick tests for peanut extract were also positive. In consequence, the patient was counseled to strictly avoid peanut-related products, and provided with an emergency set. No adverse allergic events have occurred since for an observation time of 15 months after PBSCT. The stem cell donor was contacted and confirmed intolerance to peanuts. His specific serum IgE pattern nine month after PBSCT harvest was analysed and showed similar sensitization profiles compared to those of the transplant recipient. CONCLUSIONS: Because of the close temporal association between the onset of allergic symptoms in the PBSC recipient it is reasonable to assume that the acquired peanut allergy had been transferred from the donor to the recipient by the PBSC graft.
format Online
Article
Text
id pubmed-4745161
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47451612016-02-22 A lurking threat: transfer of peanut allergy through peripheral blood stem cell transplantation Brauns, Birka Schön, Michael P. Wulf, Gerald Mempel, Martin World Allergy Organ J Case Report BACKGROUND: There exist several reports of atopy and allergen-specific IgE-mediated hypersensitivity transferred by bone marrow transplantation, and it has been concluded that the transfer of allergic reactivity results from adoptive transfer of IgE-producing donor-derived B- and/or plasma cells. To the best of our knowledge we report the first case of peanut allergy after PBSCT. CASE PRESENTATION: A 55-year-old anciently non allergic man with secondary acute myeloid leukemia (AML) received an allogeneic peripheral blood stem cell transplantation from a matched unrelated donor following reduced-intensity conditioning. On day 32 after PBSCT, while still on prophylactic systemic immunosuppression, the patient noticed a first episode of angioedema with swelling of the nasal and oral mucosa 30 min after consuming peanut puffs. In a second episode, eight months after PBSCT, he again developed angioedema, generalized pruritus and nausea within minutes after eating biscuits containing hazelnut and peanut. Moreover, after topical application of a peanut oil-containing ointment, the patient experienced facial erythema and angioedema. Nine months after PBSCT an evaluation for peanut allergy revealed a highly increased specific IgE to peanut of 75.9 kU/l. Accordingly, skin prick tests for peanut extract were also positive. In consequence, the patient was counseled to strictly avoid peanut-related products, and provided with an emergency set. No adverse allergic events have occurred since for an observation time of 15 months after PBSCT. The stem cell donor was contacted and confirmed intolerance to peanuts. His specific serum IgE pattern nine month after PBSCT harvest was analysed and showed similar sensitization profiles compared to those of the transplant recipient. CONCLUSIONS: Because of the close temporal association between the onset of allergic symptoms in the PBSC recipient it is reasonable to assume that the acquired peanut allergy had been transferred from the donor to the recipient by the PBSC graft. BioMed Central 2016-02-08 /pmc/articles/PMC4745161/ /pubmed/26904156 http://dx.doi.org/10.1186/s40413-016-0093-4 Text en © Brauns et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Brauns, Birka
Schön, Michael P.
Wulf, Gerald
Mempel, Martin
A lurking threat: transfer of peanut allergy through peripheral blood stem cell transplantation
title A lurking threat: transfer of peanut allergy through peripheral blood stem cell transplantation
title_full A lurking threat: transfer of peanut allergy through peripheral blood stem cell transplantation
title_fullStr A lurking threat: transfer of peanut allergy through peripheral blood stem cell transplantation
title_full_unstemmed A lurking threat: transfer of peanut allergy through peripheral blood stem cell transplantation
title_short A lurking threat: transfer of peanut allergy through peripheral blood stem cell transplantation
title_sort lurking threat: transfer of peanut allergy through peripheral blood stem cell transplantation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745161/
https://www.ncbi.nlm.nih.gov/pubmed/26904156
http://dx.doi.org/10.1186/s40413-016-0093-4
work_keys_str_mv AT braunsbirka alurkingthreattransferofpeanutallergythroughperipheralbloodstemcelltransplantation
AT schonmichaelp alurkingthreattransferofpeanutallergythroughperipheralbloodstemcelltransplantation
AT wulfgerald alurkingthreattransferofpeanutallergythroughperipheralbloodstemcelltransplantation
AT mempelmartin alurkingthreattransferofpeanutallergythroughperipheralbloodstemcelltransplantation
AT braunsbirka lurkingthreattransferofpeanutallergythroughperipheralbloodstemcelltransplantation
AT schonmichaelp lurkingthreattransferofpeanutallergythroughperipheralbloodstemcelltransplantation
AT wulfgerald lurkingthreattransferofpeanutallergythroughperipheralbloodstemcelltransplantation
AT mempelmartin lurkingthreattransferofpeanutallergythroughperipheralbloodstemcelltransplantation